In addition, its expression in triple-negative breast cancer cells, which are resistant to many chemotherapeutics, increased their sensitivity to doxorubicin and mitoxantrone significantly by directly binding to ABCG2 mRNA and regulating ABCG2 expression [10]. Here, ABCG2 is linked to triple-negative breast carcinoma.